Alzheimer’s: The United States approves the first new drug for the disease in 20 years


Aldo Sirsa while receiving a dose of the drug
comment on the photo,

Aldo Sirissa while receiving a dose of the drug

US regulators have approved the first new Alzheimer’s treatment in nearly 20 years, paving the way for its use in Britain.

Aducanumab targets the underlying cause of Alzheimer’s disease, the most common form of dementia, rather than its symptoms.

Alzheimer’s charities welcomed the news that a new treatment for the condition had been approved.

But scientists are divided about its possible effect due to uncertainty about the results of the experiment.


Please enter your comment!
Please enter your name here